Literature DB >> 18461428

B-type natriuretic peptide and wall stress in dilated human heart.

P Alter1, H Rupp, M B Rominger, A Vollrath, F Czerny, J H Figiel, P Adams, F Stoll, K J Klose, B Maisch.   

Abstract

Background Although B-type natriuretic peptide (BNP) is used as complimentary diagnostic tool in patients with unknown thoracic disorders, many other factors appear to trigger its release. In particular, it remains unresolved to what extent cellular stretch or wall stress of the whole heart contributes to enhanced serum BNP concentration. Wall stress cannot be determined directly, but has to be calculated from wall volume, cavity volume and intraventricular pressure of the heart. The hypothesis was, therefore, addressed that wall stress as determined by cardiac magnetic resonance imaging (CMR) is the major determinant of serum BNP in patients with a varying degree of left ventricular dilatation or dysfunction (LVD). Methods A thick-walled sphere model based on volumetric analysis of the LV using CMR was compared with an echocardiography-based approach to calculate LV wall stress in 39 patients with LVD and 21 controls. Serum BNP was used as in vivo marker of a putatively raised wall stress. Nomograms of isostress lines were established to assess the extent of load reduction that is necessary to restore normal wall stress and related biochemical events. Results Both enddiastolic and endsystolic LV wall stress were correlated with the enddiastolic LV volume (r = 0.54, P < 0.001; r = 0.81, P < 0.001). LV enddiastolic wall stress was related to pulmonary pressure (capillary: r = 0.69, P < 0.001; artery: r = 0.67, P < 0.001). Although LV growth was correlated with the enddiastolic and endsystolic volume (r = 0.73, P < 0.001; r = 0.70, P < 0.001), patients with LVD exhibited increased LV wall stress indicating an inadequately enhanced LV growth. Both enddiastolic (P < 0.05) and endsystolic (P < 0.01) wall stress were increased in patients with increased BNP. In turn, BNP concentration was elevated in individuals with increased enddiastolic wall stress (>8 kPa: 587 +/- 648 pg/ml, P < 0.05; >12 kPa: 715 +/- 661 pg/ml, P < 0.001; normal < or =4 kPa: 124 +/- 203 pg/ml). Analysis of variance revealed LV enddiastolic wall stress as the only independent hemodynamic parameter influencing BNP (P < 0.01). Using nomograms with "isostress" curves, the extent of load reduction required for restoring normal LV wall stress was assessed. Compared with the CMR-based volumetric analysis for wall stress calculation, the echocardiography based approach underestimated LV wall stress particularly of dilated hearts. Conclusions In patients with LVD, serum BNP was increased over the whole range of stress values which were the only hemodynamic predictors. Cellular stretch appears to be a major trigger for BNP release. Biochemical mechanisms need to be explored which appear to operate over this wide range of wall stress values. It is concluded that the diagnostic use of BNP should primarily be directed to assess ventricular wall stress rather than the extent of functional ventricular impairment in LVD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18461428     DOI: 10.1007/s11010-008-9779-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  63 in total

1.  The effect of treatment with eprosartan on pulse pressure: factors predicting response.

Authors:  Alejandro de la Sierra; Anna Muñoz; Emma Arcos; Juan Salvador López; Jordi Relats
Journal:  Can J Cardiol       Date:  2004-10       Impact factor: 5.223

2.  Role of streptomycin-sensitive stretch-activated channel in chest wall impact induced sudden death (commotio cordis).

Authors:  Arthur R Garan; Barry J Maron; Paul J Wang; N A Mark Estes; Mark S Link
Journal:  J Cardiovasc Electrophysiol       Date:  2005-04

3.  Pressure overload induces cardiac dysfunction and dilation in signal transducer and activator of transcription 6-deficient mice.

Authors:  Shungo Hikoso; Osamu Yamaguchi; Yoshiharu Higuchi; Shinichi Hirotani; Toshihiro Takeda; Kazunori Kashiwase; Tetsuya Watanabe; Masayuki Taniike; Ikuko Tsujimoto; Michio Asahi; Yasushi Matsumura; Kazuhiko Nishida; Hiroshi Nakajima; Shizuo Akira; Masatsugu Hori; Kinya Otsu
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

4.  Effect of positive inotropic agents on myosin isozyme population and mechanical activity of cultured rat heart myocytes.

Authors:  H Rupp; H J Berger; A Pfeifer; K Werdan
Journal:  Circ Res       Date:  1991-04       Impact factor: 17.367

5.  B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.

Authors:  Yoshitaka Iwanaga; Isao Nishi; Shinichi Furuichi; Teruo Noguchi; Kazuhiro Sase; Yasuki Kihara; Yoichi Goto; Hiroshi Nonogi
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

6.  Left ventricular stresses in the intact human heart.

Authors:  I Mirsky
Journal:  Biophys J       Date:  1969-02       Impact factor: 4.033

7.  NT-proANP and BNP in renovascular and in severe and mild essential hypertension.

Authors:  Hanna Mussalo; Esko Vanninen; Risto Ikäheimo; Juha Hartikainen
Journal:  Kidney Blood Press Res       Date:  2003       Impact factor: 2.687

8.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

9.  Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy.

Authors:  P Alter; H Rupp; M B Rominger; A Vollrath; F Czerny; K J Klose; B Maisch
Journal:  Can J Physiol Pharmacol       Date:  2007-08       Impact factor: 2.273

10.  Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations.

Authors:  W Grossman; E Braunwald; T Mann; L P McLaurin; L H Green
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

View more
  8 in total

Review 1.  Protein NMR in biomedical research.

Authors:  W Jahnke; H Widmer
Journal:  Cell Mol Life Sci       Date:  2004-02-26       Impact factor: 9.261

2.  Intrapericardial procedures for cardiac regeneration by stem cells: need for minimal invasive access (AttachLifter) to the normal pericardial cavity.

Authors:  H Rupp; T P Rupp; P Alter; N Jung; S Pankuweit; B Maisch
Journal:  Herz       Date:  2010-10       Impact factor: 1.443

Review 3.  MR, CT, and PET imaging in pericardial disease.

Authors:  Peter Alter; Jens H Figiel; Thomas P Rupp; Georg F Bachmann; Bernhard Maisch; Marga B Rominger
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 4.  Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease.

Authors:  Ayhan Atmanli; Ibrahim John Domian
Journal:  Trends Cell Biol       Date:  2016-12-19       Impact factor: 20.808

Review 5.  Preoperative evaluation of patients with possible coronary artery disease.

Authors:  Willem-Jan Flu; Jan-Peter van Kuijk; Sanne Hoeks; Jeroen J Bax; Don Poldermans
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

6.  Diabetic cardiomyopathy--fact or fiction?

Authors:  B Maisch; P Alter; S Pankuweit
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

Review 7.  Fiber Scaffold Patterning for Mending Hearts: 3D Organization Bringing the Next Step.

Authors:  Marleen Kristen; Madison J Ainsworth; Nino Chirico; Casper F T van der Ven; Pieter A Doevendans; Joost P G Sluijter; Jos Malda; Alain van Mil; Miguel Castilho
Journal:  Adv Healthc Mater       Date:  2019-10-11       Impact factor: 9.933

8.  Predictors and prevention of diabetic cardiomyopathy.

Authors:  Vishalakshi Chavali; Suresh C Tyagi; Paras K Mishra
Journal:  Diabetes Metab Syndr Obes       Date:  2013-04-11       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.